Adjuvant Chemotherapy Duration and Disease-Free Survival in Low-Risk Stage III Colon Cancer with N1a-b and N1c Disease: Insights from a Single-Center Retrospective Analysis [0.03%]
III期低危结肠癌N1a-b和N1c疾病辅助化疗持续时间与无病生存期：来自单中心回顾性分析的见解
Beliz Bahar Karaoğlan,İremsu Öztürk,Cihangir Akyol et al.
Beliz Bahar Karaoğlan et al.
Background: Tumor deposits (TDs) are known to have a poor prognosis independent of lymph node (LN) involvement and are considered equivalent to LN metastases in the latest staging system. In stage III colon cancer (CC), h...
Posthepatectomy Liver Failure in Patients with Splenomegaly Induced by Induction Chemotherapy for Colorectal Liver Metastases [0.03%]
结肠癌肝转移新辅助化疗后脾肿大患者的术后肝脏功能衰竭
Koki Hayashi,Yoshihiro Ono,Atsushi Oba et al.
Koki Hayashi et al.
Purpose: With advances in chemotherapy, conversion surgery is often performed for initially unresectable colorectal cancer liver metastasis (CLM). However, unexpected posthepatectomy liver failure (PHLF) is sometimes asso...
FOLFOXIRI for First-Line Treatment of Unresectable Colorectal Cancer with Liver Metastases in a Resource-Limited Setting [0.03%]
在医疗资源有限的情况下使用FOLFOXIRI治疗不可手术的伴有肝转移的结直肠癌初治患者
Vuong Dinh Thy Hao,Phan Minh Tri,Doan Tien My et al.
Vuong Dinh Thy Hao et al.
Purpose: FOLFOXIRI is a standard treatment for unresectable colorectal cancer (CRC) liver metastases. However, limited data exists on its safety and effectiveness in low-to-middle-income countries (LMICs). This prospectiv...
The Persian Version of the Fear of Progression Questionnaire's Short Form (FOPQ-SF): Psychometric Features Among Cancer Patients [0.03%]
癌症患者的恐惧进展问卷简表（FOPQ-SF）的波斯版：心理测量特征
Fatemeh Hassani Alimolk,Pandora Patterson,Fiona Elizabeth Jean McDonald et al.
Fatemeh Hassani Alimolk et al.
Introduction: Fear of progression (FOP) is a significant psychological concern among cancer patients. The Fear of Progression Questionnaire-Short Form (FOPQ-SF) is one of the significant and reliable tools to evaluate FOP...
Network Meta-analysis of Randomized Controlled Trials in Patients with Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer: Comparisons Involving Ramucirumab [0.03%]
先前治疗过的晚期胃或 gastroesophageal junction癌患者的随机对照试验的网络 meta 分析：Regorafenib 的比较研究
Yulia D&#x;yachkova,Astra M Liepa,Rajat Goel et al.
Yulia D&#x;yachkova et al.
Purpose: With relatively few direct comparisons among treatment options for previously treated advanced gastric cancer or gastroesophageal junction (GEJ) cancer, network meta-analysis (NMA) may inform evidence-based decis...
Efficacy and Safety of Anti-EGFR Therapy Rechallenge in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis [0.03%]
抗EGFR治疗重复使用疗效和安全性的系统评价和Meta分析
Francisco Cezar Aquino de Moraes,Anna Luíza Soares de Oliveira Rodrigues,Jonathan N Priantti et al.
Francisco Cezar Aquino de Moraes et al.
Background: Colorectal cancer (CRC) represents the second leading cause of cancer-related mortality worldwide, with a significant portion of patients presenting with metastatic disease at diagnosis. Resistance to initial ...
Overall Survival of Young Patients with Hepatocellular Carcinoma in Barcelona Clinic Liver Cancer Stage B in a Retrospective Study Based on a Multicenter Cohort [0.03%]
巴塞罗那肝癌B期年轻 hepatocellular carcinoma患者总生存率的多中心队列回顾性研究
Koji Fujita,Kyoko Oura,Asahiro Morishita et al.
Koji Fujita et al.
Background: Hepatocellular carcinoma (HCC) is usually diagnosed in patients at the age of > 45 years. We aimed to determine the prognosis of patients with HCC at the age of 30-44 years compared with that of patients at a ...
Multicenter Study
Journal of gastrointestinal cancer. 2024 Oct 21;56(1):8. DOI:10.1007/s12029-024-01126-3 2024
Impact of Retroperitoneal Lymphadenopathy (RPLN) on the Outcomes of Locally Advanced Gall Bladder Cancer (GBC) Following Chemotherapy (CT) or Chemotherapy Followed by Consolidation Chemoradiotherapy (CTRT) [0.03%]
化疗或术后化学免疫巩固放疗对伴发盆腔淋巴结病的局部晚期胆囊癌疗效的影响
Sushma Agrawal,Nagendra Naik,Parul Priyanka
Sushma Agrawal
Introduction: Retroperitoneal lymphadenopathy is considered a metastatic disease in GBC; however, some surgical series of radical surgery with enlarged RPLN who underwent RPLN dissection have shown results marginally infe...
Increased Proportion of the Squamous Cell Carcinoma Components Is Associated with Aggressive Behavior and a Worse Prognosis in Resected Pancreatic Adenosquamous Carcinoma [0.03%]
胰腺腺鳞癌切除标本中鳞状细胞成分比例越大提示生物学行为越凶险及预后越差
Takaaki Tatsuguchi,Daichi Kitahara,Shingo Kozono et al.
Takaaki Tatsuguchi et al.
Purpose: Pancreatic adenosquamous carcinoma (PASC) is a subtype of pancreatic cancer with a poorer prognosis than pancreatic ductal carcinoma (PDAC). The pathogenesis of this histological subtype has not been fully explai...
Perianal Mucinous Adenocarcinoma: A Case Report and a Systematic Review of the Literature [0.03%]
肛周黏液腺癌一例并文献复习
Ioannis D Gkegkes,Vassilis Milionis,Nikolaos Goutas et al.
Ioannis D Gkegkes et al.
Background: Mucinous adenocarcinoma of anus is an uncommon neoplasm of the gastrointestinal tract. In most of the cases, early diagnosis of this disease is difficult since its symptoms frequently mimic benign inflammatory...